Kristin McKay, Executive Director of Project Alive, is dedicated to accelerating treatments, expanding care, and supporting families affected by Hunter Syndrome, a disease that impacted her brother and now her son.
Geana Dyer, BS, RN, the Founder of the Cockayne Syndrome Foundation shares her experience parenting 5-year-old Ronin, filmed at the New England Regional Genetics Group (NERGG) conference.
Drs. Eric Green and Sarah Tishkoff join our host Kira Dineen for our annual recap and reflection on the biggest genetics/genomics advancements this year!
Interviews...
Kristin McKay, Executive Director of Project Alive, is dedicated to accelerating treatments, expanding care, and supporting families affected by Hunter Syndrome, a disease that impacted her brother and now her son.
Geana Dyer, BS, RN, the Founder of the Cockayne Syndrome Foundation shares her experience parenting 5-year-old Ronin, filmed at the New England Regional Genetics Group (NERGG) conference.
In the pilot episode of Gene Pool Media’s newest podcast the host Amber Sher, CGC is interviewed about the intersection of genetics, medicine, and faith.
How Italy is integrating cancer genetic testing into its public healthcare system through Negedia’s panels, powered by MGI Tech.
Greenwood Genetics Center’s Dr. Nikhil Sahajpal reveals how OGM is changing clinical diagnostics from missed structural variants to new gene disease association.
A leading expert in pediatric genetics and skeletal disorders, Dr. Janet Laegare, provides her expertise.
Drs. Christine Eng, Eric Green, and Marina Sirota share highlights of their presentations at this week’s AGBT Precision Health 2025 Meeting in California.
Beyond The Thesis with Papa PhD episode where Kira Dineen is interviewed by Dr. David Mendes about science communications, networking, and GC grad school apps.
Explore how MGI’s genomic innovation is transforming rare diseases (and even dual diagnoses) care in Turkey and around the globe from Dr. Serdar Ceylaner and Alice Peng.
Quest Diagnostics' Kristy Bouvier and Kathleen O’Brien explore how pharmacogenetics testing can optimize medications, prevent side effects, and improve treatment.